Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Jul 16 · below the Ichimoku cloud · RSI 45 · MACD above its signal
None of the 29 investors followed here reported a position in EDXC in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a EDXC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for EDXC.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.3 | -62.5 | -66.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −85.7% | ||
| 2025 | 34.8 | -26.0 | 3.2 | -22.5 | -25.8 | 31.4 | -35.8 | 23.3 | -44.3 | -13.6 | -26.5 | -53.3 | −89.9% |
| 2024 | -7.1 | 13.8 | 27.0 | -19.6 | -14.8 | 18.0 | -10.5 | -11.8 | -30.1 | 6.9 | -10.7 | -31.0 | −60.6% |
| 2023 | -3.4 | 12.5 | -14.2 | -19.5 | 3.8 | 22.6 | -4.8 | 14.9 | -17.3 | -25.5 | -31.4 | -9.8 | −60.2% |
| 2022 | 29.0 | -4.0 | 14.6 | 5.7 | -46.2 | -0.8 | 81.5 | -11.8 | 151.9 | -20.0 | -33.7 | -17.0 | +41.9% |
| 2021 | 11.5 | 58.4 | -28.6 | 27.3 | -37.6 | 1.0 | -21.1 | -24.8 | -17.9 | -5.3 | 0.6 | -37.0 | −70.4% |
| 2020 | -10.5 | -25.3 | 2.4 | 22.8 | -23.0 | 30.1 | -19.5 | -13.4 | 2.7 | -5.3 | 59.1 | 21.4 | +10.3% |
| 2019 | 254.3 | -17.1 | 112.1 | 64.2 | -26.9 | 3.7 | -21.6 | -35.0 | -40.3 | 36.3 | -30.9 | -13.4 | +92.3% |
| 2018 | -1.1 | -6.4 | -21.1 | -6.9 | -11.6 | 7.4 | 13.1 | -8.4 | -7.9 | 2.7 | 0.5 | 11.3 | −29.3% |
| 2017 | 55.3 | -37.9 | 14.6 | 52.2 | -19.4 | -37.2 | 25.5 | -14.3 | 27.9 | -5.5 | -17.3 | 62.4 | +48.6% |
| 2016 | -25.9 | 14.3 | 93.1 | -11.0 | 9.1 | -6.7 | 1.8 | 0.7 | -5.9 | 114.8 | -27.3 | 11.5 | +148.7% |
| 2015 | 21.6 | -24.4 | 20.6 | -14.6 | -14.6 | 0.0 | -9.7 | -25.9 | -39.2 | 14.0 | 14.8 | 18.9 | −48.9% |
| 2014 | 173.0 | 6.4 | 16.3 | -42.0 | 0.0 | -22.8 | -35.3 | -13.8 | -15.2 | 41.5 | -13.3 | -43.1 | −50.0% |
| 2013 | 61.1 | 327.6 | 22.6 | 48.7 | 6.2 | -37.5 | -6.7 | 2.1 | 34.3 | -55.2 | 41.9 | 21.3 | +722.2% |
| 2012 | -9.0 | -42.9 | 130.8 | -56.7 | 28.8 | 26.9 | -5.9 | 25.0 | 0.0 | -10.0 | -77.8 | 350.0 | −10.0% |
| 2011 | 14.3 | 0.0 | 150.0 | -25.0 | 20.0 | -27.8 | 76.9 | -47.0 | -26.2 | 0.0 | 0.0 | 11.1 | +42.9% |
| 2010 | 13.3 | -41.2 | 0.0 | 0.0 | 0.0 | -50.0 | 300.0 | -52.5 | 5.3 | 10.0 | -27.3 | 337.5 | +133.3% |
| 2009 | 500.0 | -50.0 | 333.3 | -15.4 | 9.1 | -8.3 | -9.1 | -49.0 | 13.7 | -39.7 | -2.9 | -11.8 | +200.0% |
| 2008 | -25.0 | 0.0 | -11.1 | 12.5 | -44.4 | -20.0 | 75.0 | -14.3 | 50.0 | -55.6 | -50.0 | -50.0 | −91.7% |
| 2007 | 40.0 | 7.1 | -31.1 | -19.4 | 0.0 | 56.0 | 10.3 | -30.2 | -13.3 | 0.0 | -57.7 | 9.1 | −60.0% |
No analyst coverage for this instrument.
Endexx Corporation develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally. The company offers cannabidiol oils, topicals, capsules, snacks, and beverages, as well as equine products for dogs and cats under the PhytoBites brand. It serves medical, biotech, and life science industries. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. The company is based in Cave Creek, Arizona.
No recent headlines.